Development of novel therapeutics to inhibit cell proliferation viaPOU6F1 in ovarian clear cell carcinoma
Development of novel therapeutics to inhibit cell proliferation viaPOU6F1 in ovarian clear cell carcinoma
批准号:
23791857
负责人:
YOSHIOKA Norihito
金额:
$2.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ARID1A, a member of SWI/SNF chromatin remodeling complex, whose members have helices and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. Loss of the ARID1A (a putative tumor suppressor) protein BAF250a has recently been described as a frequent event in ovarian clear cell carcinoma. In this study, we report that restoring wild-type ARID1A expression in ovarian clear cell carcinoma cells that harbor ARID1A mutations is sufficient to suppress cell proliferation and enhance anticancer agent sensitivity. Gene expression analysis identified several down stream targets of ARID1A. Our results provide functional evidence in support of the hypothesis that ARID1A is a bona fide tumor suppressor gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
POU6F1 is the transcription factor which may be involved in cell proliferation of clear cell adeno carcinoma of the ovary
POU6F1是可能参与卵巢透明细胞腺癌细胞增殖的转录因子
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[鈴木佳克, 松浦綾乃, 山本珠生., 吉岡 範人]
通讯作者:
吉岡 範人
DOI:
10.1111/j.1749-0774.2009.00074.x
发表时间:
2009-11
期刊:
Human Cell
影响因子:
4.3
作者:
[N. Yoshioka;N. Suzuki;A. Uekawa;K. Kiguchi;B. Ishizuka]
通讯作者:
N. Yoshioka;N. Suzuki;A. Uekawa;K. Kiguchi;B. Ishizuka
POU6F1 IS THE TRANSCRIPTION FACTOR THAT MIGHT BE INVOLVED IN CELL PROLIFERATION OF
POU6F1 是可能参与细胞增殖的转录因子
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Norihito Yoshioka, A.Tozawa-Ono, K.Kiguchi, N.Suzuki]
通讯作者:
N.Suzuki
海外基金